Biofabrication of Collagen Tissue‐Engineered Blood Vessels with Direct Co‐Axial Extrusion

Abstract

Cardiovascular diseases are considered one of the worldwide causes of death, with atherosclerosis being the most predominant. Nowadays, the gold standard treatment is blood vessel re-placement by bypass surgery; however, autologous source is not always possible. Thereby, tissue-engineered blood vessels (TEBVs) are emerging as a potential alternative source. In terms of com-position, collagen has been selected in many occasions to develop TEBVs as it is one of the main extracellular matrix components of arteries. However, it requires specific support or additional pro-cessing to maintain the tubular structure and appropriate mechanical properties. Here, we present a method to develop support‐free collagen TEBVs with co‐axial extrusion in a one‐step procedure with high concentrated collagen. The highest concentration of collagen of 20 mg/mL presented a burst pressure of 619.55 ± 48.77 mmHg, being able to withstand perfusion of 10 dynes/cm2. Viability results showed a high percentage of viability (86.1 and 85.8% with 10 and 20 mg/mL, respectively) of human aortic smooth muscle cells (HASMCs) and human umbilical vein endothelial cells (HU‐ VEC) after 24 h extrusion. Additionally, HUVEC and HASMCs were mainly localized in their re-spective layers, mimicking the native distribution. All in all, this approach allows the direct extrusion of collagen TEBVs in a one‐step procedure with enough mechanical properties to be perfused.